Grace Therapeutics
GRCE
26 hedge funds and large institutions have $1.88M invested in Grace Therapeutics in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 6 closing their positions.
42% more capital invested
Capital invested by funds: $1.33M → $1.88M (+$554K)
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
8% more funds holding
Funds holding: 24 → 26 (+2)
0.01% more ownership
Funds ownership: 0.02% → 0.03% (+0.01%)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$886K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$56.3K |
| 3 |
Squarepoint
New York
|
+$38.2K |
| 4 |
Millennium Management
New York
|
+$19K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$13.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$127K |
| 2 |
Morgan Stanley
New York
|
-$101K |
| 3 |
VF
Virtu Financial
New York
|
-$92.1K |
| 4 |
Jane Street
New York
|
-$60K |
| 5 |
Two Sigma Advisers
New York
|
-$31K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SFA
26
Sequoia Financial Advisors
Akron,
Ohio
| – | -$6K | -208 | Closed |
|
|
PCIA
27
Prime Capital Investment Advisors
Overland Park,
Kansas
| – | -$1K | -42 | Closed |
|
28
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | +$244 | +10 | New |
|
GRCE Hedge Fund Activity: Q2 2021 in Review
26 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Grace Therapeutics (GRCE) for Q2 2021, worth a combined $1.88M — up 42% from $1.33M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new GRCE positions and 6 closed out — a net gain of 2 holders — while 2 added to existing stakes and 4 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $886K. The largest seller was Bank of Montreal, cutting an estimated $127K.
- 26 institutional investors held Grace Therapeutics (GRCE) as of Q2 2021, up from 24 in Q1 2021.
- Funds reported $1.88M of Grace Therapeutics stock for Q2 2021, up 42% quarter-over-quarter.
- 8 funds opened new Grace Therapeutics positions in Q2 2021 and 6 closed out, a net change of +2 holders.
- The largest Grace Therapeutics buyer in Q2 2021 was Renaissance Technologies, an estimated $886K added.
- The largest Grace Therapeutics seller in Q2 2021 was Bank of Montreal, an estimated $127K sold.
Based on aggregated 13F filings for Q2 2021.